Primary Record
faropenem
- In stock
- 6,175 g
- Purity
- 99.0 %
- CAS
- 106560-14-9
Compound Identifiers & Properties
- CAS
- 106560-14-9
- PubChem CID
- 65894
- SMILES
- C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)[C@H]3CCCO3)C(=O)O)O
- Canonical SMILES
- C[C@@H](O)[C@H]1C(=O)N2C(C(=O)O)=C([C@H]3CCCO3)S[C@H]12
Names & Synonyms
- faropenem
- Fropenem
- Faropenem sodium
- Fropenum sodium
- faropenemum
- Fropenem sodium
- Fropenem [INN]
- 106560-14-9
- Faropenem medoxomil
- Faropenem [USAN]
- faropenem sodium hemipentahydrate
- Faropenem sodium hydrate
- Faropenem [USAN:INN]
- FAROPENEM [INN]
- FAROPENEM [MI]
- RefChem:139969
- F52Y83BGH3
- GlyTouCan:G87527IP
- UNII-F52Y83BGH3
- DTXSID0046430
- CHEBI:51257
- D02IIW
- FAROPENEM [WHO-DD]
- C12H15NO5S
- C12H15NO5S.Na
- DTXCID8026430
- SCHEMBL239381
- UNII-7O46G914RQ
- ALP 201
- AC1L246Z
- CCRIS 6723
- CHEMBL556262
- SUN 5555
- CHEBI:51788
- CTK0H9760
- GTPL10808
- J01DI03
- HGGAKXAHAYOLDJ-FHZUQPTBSA-N
- SY5555
- YM-044
- C12-H15-N-O5-S.Na
- CID65894
- EBD29876
- faropenem medoxil\nfaropenem medoxil
- G87527IP
- HY-A0035
- ZINC3959242
- C12-H15-N-O5-S
- Tox21_112175
- BDBM50483324
- NCGC00164546-02
- compound 1 [PMID: 9216830]
- AKOS015895072
- Tox21_112175_1
- AN-9440
- CB11318
- CS-O-30917
- DB12190
- EBC-616439
- VA10981
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-oxolan-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- NCGC00164546-01
- AN-33826
- 122547-49-3 (Na)
- J550.682D
- TL8000237
- 1723A
- CAS-106560-14-9
- CS-0006739
- NS00069663
- (5R,6S)-6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydrofuran-2-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- H11961
- 560F149
- A801462
- SR-01000872591
- (+)-(5R,6S)-6-((1R)-1-Hydroxyethyl)-7-oxo-3-((2R)-tetrahydro-2-furyl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- I06-0479
- Q1397045
- SR-01000872591-1
- 122547-49-3
- 6alpha-[(1R)-1-hydroxyethyl]-2-[(2R)-tetrahydrofuran-2-yl]-2,3-didehydropenam-3-carboxylic acid
- 6alpha-[(R)-1-hydroxyethyl]-2-[(R)-tetrahydrofuran-2-yl]pen-2-em-3-carboxylic acid
- (5R,6S)-6-((1R)-1-HYDROXYETHYL)-7-OXO-3-((2R)-TETRAHYDROFURAN-2-YL)-4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID
- (5R,6S)-6-((R)-1-Hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- (5r,6s)-6-(1-Hydroxyethyl)-7-Oxo-3-[(2r)-Oxolan-2-Yl]-4-Thia-1-Azabicyclo[3.2.0]hept-2-Ene-2-Carboxylic Acid
- (5R,6S,8R,2'R)-2-(2'-tetrahydrofuryl)-6-hydroxyethylpenem-3-carboxylate
- 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid,6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-, (5R,6S)-
- 6-[(1R)-1-Hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid monosodium salt hemipentahydrate
- FPM
- (5R,6S)-6-((1R)-1-hydroxyethyl)-7-oxo-3-((2R)-oxolan-2-yl)-4-thia-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid
- (5R,6S)-6-(1(R)-Hydroxyethyl)-2-(2(R)-tetrahydrofuryl)penem-3-carboxylic acid monosodium salt
- [5R,6S,(+)]-6beta-[(1R)-1-Hydroxyethyl]-7-oxo-3-[[(2R)-tetrahydrofuran]-2beta-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- [5R,6S,(+)]-6beta-[(R)-1-Hydroxyethyl]-7-oxo-3-[[(2R)-tetrahydrofuran]-2beta-yl]-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid
- 141702-36-5
- 4-THIA-1-AZABICYCLO(3.2.0)HEPT-2-ENE-2-CARBOXYLIC ACID, 6-((1R)-1-HYDROXYETHYL)-7-OXO-3-((2R)-TETRAHYDRO-2-FURANYL)-,(5R,6S)
- 4-Thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylicacid, 6-[(1R)-1-hydroxyethyl]-7-oxo-3-[(2R)-tetrahydro-2-furanyl]-, (5R,6S)-